OBALON THERAPEUTICS INC·4

Jan 30, 6:47 PM ET

VandenBerg Amy 4

4 · OBALON THERAPEUTICS INC · Filed Jan 30, 2018

Insider Transaction Report

Form 4
Period: 2018-01-29
VandenBerg Amy
VP of Reg. and Clin. Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-29$0.87/sh+4,022$3,4994,022 total
  • Exercise/Conversion

    Common Stock

    2018-01-29$0.87/sh+1,087$9465,109 total
  • Exercise/Conversion

    Common Stock

    2018-01-29$1.31/sh+1,541$2,0196,650 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2018-01-294,0220 total
    Exercise: $0.87From: 2012-12-15Exp: 2018-12-15Common Stock (4,022 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2018-01-291,0870 total
    Exercise: $0.87From: 2013-12-24Exp: 2020-01-27Common Stock (1,087 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2018-01-291,5410 total
    Exercise: $1.31From: 2014-10-08Exp: 2021-01-26Common Stock (1,541 underlying)

Documents

1 file
  • 4
    marketforms-40861.xmlPrimary

    PRIMARY DOCUMENT